Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yabo Zhou

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Cancer Research|August 5, 2021
Hypoxia Promotes Breast Cancer Cell Growth by Activating a Glycogen Metabolic ProgramKe Tang, Liyan Zhu, Jie Chen, et al.
Cancer Research|November 10, 2020
Cell Softness Prevents Cytolytic T-cell Killing of Tumor-Repopulating CellsYuying Liu, Tianzhen Zhang, Haizeng Zhang, et al.
Nature Cell Biology|September 11, 2024
Ammonia-induced lysosomal and mitochondrial damage causes cell death of effector CD8<sup>+</sup> T cellsHuafeng Zhang, Jincheng Liu, Wu Yuan, et al.
Cellular & Molecular Immunology|January 5, 2022
SARS-CoV-2 treatment effects induced by ACE2-expressing microparticles are explained by the oxidized cholesterol-increased endosomal pH of alveolar macrophagesZhenfeng Wang, Jiadi Lv, Pin Yu, et al.
Nature Cell Biology|March 16, 2022
Gasdermin E mediates resistance of pancreatic adenocarcinoma to enzymatic digestion through a YBX1-mucin pathwayJiadi Lv, Yuying Liu, Siqi Mo, et al.
Nature Communications|March 2, 2018
Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotypeDegao Chen, Jing Xie, Roland Fiskesund, et al.
Science Translational Medicine|February 1, 2023
Epigenetic modification of <i>CSDE1</i> locus dictates immune recognition of nascent tumorigenic cellsJiadi Lv, Yabo Zhou, Nannan Zhou, et al.
Nature Communications|May 3, 2018
Publisher Correction: Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotypeDegao Chen, Jing Xie, Roland Fiskesund, et al.
Nature Chemical Biology|March 14, 2026
IDO1 regulating ROS rhythm reveals glycogenolysis/PPP as a cancer treatment targetNannan Zhou, Zheng Ling, Xiankai Cao, et al.
Nature Immunology|November 3, 2023
Tumor cell-released kynurenine biases MEP differentiation into megakaryocytes in individuals with cancer by activating AhR-RUNX1Li Zhou, Dongxiao Wu, Yabo Zhou, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Cancer Research|August 5, 2021
Hypoxia Promotes Breast Cancer Cell Growth by Activating a Glycogen Metabolic ProgramKe Tang, Liyan Zhu, Jie Chen, et al.
Cancer Research|November 10, 2020
Cell Softness Prevents Cytolytic T-cell Killing of Tumor-Repopulating CellsYuying Liu, Tianzhen Zhang, Haizeng Zhang, et al.
Nature Cell Biology|September 11, 2024
Ammonia-induced lysosomal and mitochondrial damage causes cell death of effector CD8<sup>+</sup> T cellsHuafeng Zhang, Jincheng Liu, Wu Yuan, et al.
Cellular & Molecular Immunology|January 5, 2022
SARS-CoV-2 treatment effects induced by ACE2-expressing microparticles are explained by the oxidized cholesterol-increased endosomal pH of alveolar macrophagesZhenfeng Wang, Jiadi Lv, Pin Yu, et al.
Nature Cell Biology|March 16, 2022
Gasdermin E mediates resistance of pancreatic adenocarcinoma to enzymatic digestion through a YBX1-mucin pathwayJiadi Lv, Yuying Liu, Siqi Mo, et al.
Nature Communications|March 2, 2018
Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotypeDegao Chen, Jing Xie, Roland Fiskesund, et al.
Science Translational Medicine|February 1, 2023
Epigenetic modification of <i>CSDE1</i> locus dictates immune recognition of nascent tumorigenic cellsJiadi Lv, Yabo Zhou, Nannan Zhou, et al.
Nature Communications|May 3, 2018
Publisher Correction: Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotypeDegao Chen, Jing Xie, Roland Fiskesund, et al.
Nature Chemical Biology|March 14, 2026
IDO1 regulating ROS rhythm reveals glycogenolysis/PPP as a cancer treatment targetNannan Zhou, Zheng Ling, Xiankai Cao, et al.
Nature Immunology|November 3, 2023
Tumor cell-released kynurenine biases MEP differentiation into megakaryocytes in individuals with cancer by activating AhR-RUNX1Li Zhou, Dongxiao Wu, Yabo Zhou, et al.
Pageof 4